Invention Grant
US08455248B2 Cells useful for immuno-based Botulinum toxin serotype A activity assays
有权
可用于基于免疫的肉毒杆菌毒素血清型A活性测定的细胞
- Patent Title: Cells useful for immuno-based Botulinum toxin serotype A activity assays
- Patent Title (中): 可用于基于免疫的肉毒杆菌毒素血清型A活性测定的细胞
-
Application No.: US13339179Application Date: 2011-12-28
-
Publication No.: US08455248B2Publication Date: 2013-06-04
- Inventor: Hong Zhu , Joanne Wang , Birgitte P. S. Jacky , D. Dianne Hodges , Fernandez-Salas Ester
- Applicant: Hong Zhu , Joanne Wang , Birgitte P. S. Jacky , D. Dianne Hodges , Fernandez-Salas Ester
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Kenton Abel; Debra Condino
- Main IPC: C12N15/85
- IPC: C12N15/85
Abstract:
The present specification discloses clonal cell lines susceptible to BoNT/A intoxication, methods of producing such clonal cell lines, and methods of detecting Botulinum toxin serotype A activity using such clonal cell lines.
Public/Granted literature
- US20120156769A1 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays Public/Granted day:2012-06-21
Information query
IPC分类:
